Signatur Biosciences

Services

Signatur Biosciences specializes in precision diagnostics for complex diseases, starting with breast cancer prognosis. The company offers simple blood tests that can be easily run by local hospital labs, significantly reducing turnaround times from over three weeks to just a few days, and at half the cost. Their innovations make use of molecular technology to simplify diagnosing complex diseases, eliminating the need for laborious tests and expensive machines. Signatur Biosciences is expanding PCR testing to cover a broader range of conditions, aiming to make state-of-the-art diagnostics accessible to a wider audience.

Founders

The founders of Signatur Biosciences are Dr. John Goertz and Celestin de Wergifosse. Dr. John Goertz serves as the Chief Scientific Officer, bringing expertise in bioengineering and a background in physics and cell & molecular biology. He is an alumnus of the University of Maryland, College Park, and Seattle University. Celestin de Wergifosse functions as the CEO, having been involved in startups from a young age. He holds a background in bio-engineering from Imperial College London. Both founders bring a wealth of experience and knowledge to steer Signatur Biosciences toward its innovative goals.

History of Signatur Biosciences

Signatur Biosciences was launched in 2022 and is an early-stage company located in London, England. The company participated in Y Combinator's S22 batch, which provided foundational support and funding. Since its inception, Signatur Biosciences has focused on making precision diagnostics more accessible. The company's molecular technology and PCR testing innovations are central to their mission of transforming medical diagnostics, bringing cutting-edge healthcare solutions to more people.

Industry and Sub-industry

Signatur Biosciences operates within the healthcare industry, specifically in the diagnostics sub-industry. Their primary focus is on developing accessible and cost-effective diagnostic solutions for complex diseases. This niche allows them to leverage advancements in molecular technology to bring sophisticated diagnostic capabilities to more widely accessible PCR equipment.

Regions Served by Signatur Biosciences

Signatur Biosciences serves multiple regions including the United Kingdom, Europe, and offers both remote and partly remote services. The company's approach ensures that their diagnostic solutions can reach a broad audience, fulfilling their mission to make advanced healthcare accessible to everyone.